Trials / Sponsors / Galena Biopharma, Inc.
Galena Biopharma, Inc.
Industry · 3 registered clinical trials.
| Status | Trial | Phase | Started |
|---|---|---|---|
| Completed | A Study of Anagrelide Controlled Release (GALE-401) in Patients With High Platelet Counts Due to Bone Marrow D Thrombocytosis, Myeloproliferative Neoplasms | Phase 2 | 2014-05-01 |
| Completed | Observational Registry Study of Quality of Life When Treating BTcP With Abstral Quality of Life, Breakthrough Cancer Pain | — | 2013-10-01 |
| Completed | Efficacy and Safety Study of NeuVax™ (Nelipepimut-S or E75) Vaccine to Prevent Breast Cancer Recurrence Breast Cancer With Low to Intermediate HER2 Expression | Phase 3 | 2011-11-01 |